Moreover, CKD patients with high indoxyl sulfate and kynurenine were predisposed to arteriovenous thrombosis after vascular injury through the uremic solute-AhR-tissue factor axis [75], hinting that AhR antagonists may also be novel targets for anti-thrombotic therapy. This evidence concerns the gene AHR and chronic kidney disease.